89618-77-9: Bortezomib Impurity 20

Bortezomib Impurity 20 (CAS No: 89618-77-9) or (3aS,4S,6S,7aR)-2-((S)-1-chloro-2-methylpropyl)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborole is associate impurity of Bortezomib. Bortezomib is employed to treat people with multiple myeloma (a type of cancer of the bone marrow). bortezomib is during a category of medicines known as antineoplastic agents.

Additional information

Catalogue No.

VE007401

CAS No.

89618-77-9

Molecular Formula

C14H24BClO2

Molecular Weight

270.61 g/mol

IUPAC Name

(3aS, 4S, 6S, 7aR)-2-((S)-1-chloro-2-methylpropyl)-3a, 5, 5-trimethylhexahydro-4, 6-methanobenzo[d][1, 3, 2]dioxaborole

References

“Sci-Hub, Analysis of Two Commercially Available Bortezomib Products: Differences in Assay of Active Agent and Impurity Profile, 10.1208/S12249-010-9554-1.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1208/s12249-010-9554-1.

Status

In-stock